107 related articles for article (PubMed ID: 8094342)
1. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model.
Bowes MP; Zivin JA; Rothlein R
Exp Neurol; 1993 Feb; 119(2):215-9. PubMed ID: 8094342
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
Lapchak PA
Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
[TBL] [Abstract][Full Text] [Related]
3. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
Asahi M; Asahi K; Wang X; Lo EH
J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
[TBL] [Abstract][Full Text] [Related]
4. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
[TBL] [Abstract][Full Text] [Related]
5. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
Lapchak PA
Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
[TBL] [Abstract][Full Text] [Related]
6. 3alpha-OL-5-beta-pregnan-20-one hemisuccinate, a steroidal low-affinity NMDA receptor antagonist improves clinical rating scores in a rabbit multiple infarct ischemia model: synergism with tissue plasminogen activator.
Lapchak PA
Exp Neurol; 2006 Feb; 197(2):531-7. PubMed ID: 16300757
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy in experimental embolic stroke.
Overgaard K
Cerebrovasc Brain Metab Rev; 1994; 6(3):257-86. PubMed ID: 7811566
[TBL] [Abstract][Full Text] [Related]
8. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy.
Bowes MP; Rothlein R; Fagan SC; Zivin JA
Neurology; 1995 Apr; 45(4):815-9. PubMed ID: 7723976
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain.
Chopp M; Li Y; Jiang N; Zhang RL; Prostak J
J Cereb Blood Flow Metab; 1996 Jul; 16(4):578-84. PubMed ID: 8964796
[TBL] [Abstract][Full Text] [Related]
12. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
Wang CX; Ding X; Shuaib A
Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
[TBL] [Abstract][Full Text] [Related]
13. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule.
Clark WM; Madden KP; Rothlein R; Zivin JA
J Neurosurg; 1991 Oct; 75(4):623-7. PubMed ID: 1885980
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits.
Lapchak PA
Brain Res; 2007 Sep; 1167():123-8. PubMed ID: 17673188
[TBL] [Abstract][Full Text] [Related]
15. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
16. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium.
Tsujikawa A; Ogura Y; Hiroshiba N; Miyamoto K; Kiryu J; Tojo SJ; Miyasaka M; Honda Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1183-90. PubMed ID: 10235552
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ischemia/reperfusion injury after pancreas transplantation and reduction by application of monoclonal antibodies against ICAM-1 in the rat.
Keck T; Werner J; Schneider L; Gebhard MM; Klar E
Surgery; 2003 Jul; 134(1):63-71. PubMed ID: 12874584
[TBL] [Abstract][Full Text] [Related]
18. 16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke.
Bednar MM; Gross CE; Russell SR; Fuller SP; Ahern TP; Howard DB; Falck JR; Reddy KM; Balazy M
Neurosurgery; 2000 Dec; 47(6):1410-8; discussion 1418-9. PubMed ID: 11126912
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of postlaminectomy epidural fibrosis with monoclonal antibodies against intercellular adhesion molecule-1 and CD-18.
Sabuncuoğlu H; Bavbek M; Sabuncuoğlu B; Gadelha E; Köse K; Preul M
Spine J; 2007; 7(4):459-65. PubMed ID: 17630144
[TBL] [Abstract][Full Text] [Related]
20. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
Lapchak PA; Zivin JA
Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
